Cardiology
RSSArticles
-
Another Reason to Avoid Unnecessary Transfusions
A growing body of literature describes an association between packed red blood cell (pRBC) transfusions and nosocomial infections.1,2 Shorr and colleagues set out to add to this by investigating the relationship between pRBC transfusions and bloodstream infections (BSI) in a large heterogeneous population of ICU patients. -
Full August 2005 Issue in PDF
-
Pharmacology Watch: Antibiotic Treatment of Acute Lower Respiratory Infection
What to do with the Cox-2s; Can Mucomyst Prevent CIN?; Benzodiazepines and Medicare Coverage; FDA Actions -
Special Feature: Managing Bronchopleural Fistula During Mechanical Ventilation
Development of a Bronchopleural Fistula (BPF) in a patient receiving mechanical ventilation is a serious complication that causes concern on the part of caregivers and often prompts a variety of changes in management. -
Full October 3, 2005 Issue in PDF
-
Pertussis in the Emergency Department
Pertussis, or whooping cough, was first described in the 16th century, and the causative agent was isolated in 1906. Nonetheless, pertussis remained a major cause of morbidity and mortality among ch ildren well into the 20th century. -
Oil of Lemon Eucalyptus as an Insect Repellent
Frost AC. Oil of lemon eucalyptus as an insect repellent. Altern Med Alert 2005;8(8):85-89. -
Treatment Alternatives for Chronic Hepatitis B Virus Infection: A Cost-Effectiveness Analysis
By Malcolm Robinson, MD, FACP, FACG Emeritus Clinical Professor of Medicine, University of Oklahoma College of Medicine, Oklahoma City, OK Dr. Robinson serves as a consultant for TAP, Pfizer, Janssen, Eisai, J&J-Merck, and Procter & Gamble, is on the speakers bureau of Janssen, Eli Lilly, Solvay, TAP, and Aventis, and does research for Forest Labs, Wyeth-Ayerst, AstraZeneca, and Centocor. -
Treatment of Tuberculosis and Latent Tuberculosis Infection
The treatment of pulmonary tuberculosis is divided into an initial phase of four drugs for two months.
-
Pharmacology Update Medroxyprogesterone Acetate Injection (depo-subQ provera 104)
By William T. Elliott, MD, FACP, and James Chan, PhD, PharmD Dr. Elliott is Chair, Formulary Committee, Northern California Kaiser Permanente; Associate Clinical Professor of Medicine, University of California, San Francisco; Dr. Chan is Pharmacy Quality and Outcomes Manager, Kaiser Permanente, Oakland, CA. Drs. Chan and Elliott report no financial relationships to this field of study.